Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - Deferred ChargesAmortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Aemetis (AMTX) EBITDA (2016 - 2025)

Aemetis has reported EBITDA over the past 14 years, most recently at -$5.6 million for Q4 2025.

  • Quarterly results put EBITDA at -$5.6 million for Q4 2025, up 66.74% from a year ago — trailing twelve months through Dec 2025 was -$78.0 million (up 11.61% YoY), and the annual figure for FY2025 was -$78.0 million, up 11.61%.
  • EBITDA for Q4 2025 was -$5.6 million at Aemetis, up from -$24.5 million in the prior quarter.
  • Over the last five years, EBITDA for AMTX hit a ceiling of $30.5 million in Q3 2023 and a floor of -$67.1 million in Q3 2022.
  • Median EBITDA over the past 5 years was -$20.6 million (2022), compared with a mean of -$18.5 million.
  • Peak annual rise in EBITDA hit 145.35% in 2023, while the deepest fall reached 4117.53% in 2023.
  • Aemetis' EBITDA stood at -$930000.0 in 2021, then plummeted by 2333.12% to -$22.6 million in 2022, then decreased by 12.84% to -$25.5 million in 2023, then surged by 34.44% to -$16.7 million in 2024, then soared by 66.74% to -$5.6 million in 2025.
  • The last three reported values for EBITDA were -$5.6 million (Q4 2025), -$24.5 million (Q3 2025), and -$23.4 million (Q2 2025) per Business Quant data.